Do health professionals know about overdiagnosis in screening, and how are they dealing with it? A mixed-methods systematic scoping review

Veerle Piessens(Ghent University), Stefan Heytens(Ghent University), Ann Van Hecke(Ghent University), Emelien Lauwerier(Ghent University Hospital), Florian Stul(Ghent University), An De Sutter(Ghent University), An Piessens(Karel de Grote Hogeschool), John Brodersen(University of Copenhagen)
PLoS ONE
February 3, 2025
10.1371/journal.pone.0315247
Cited by 5

Related Papers

The Danish Randomized Lung Cancer CT Screening Trial—Overall Design and Results of the Prevalence Round
|Journal of Thoracic Oncology|2009|440
CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT
|Thorax|2012|391
Overdiagnosis: what it is and what it isn’t
|BMJ Evidence-Based Medicine|2018|368
Results of the Randomized Danish Lung Cancer Screening Trial with Focus on High-Risk Profiling
|American Journal of Respiratory and Critical Care Medicine|2015|343
Long-Term Psychosocial Consequences of False-Positive Screening Mammography
|The Annals of Family Medicine|2013|342